These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25019531)

  • 1. Epistatic interaction of ERAP1 and HLA-B in Behçet disease: a replication study in the Spanish population.
    Conde-Jaldón M; Montes-Cano MA; García-Lozano JR; Ortiz-Fernández L; Ortego-Centeno N; González-León R; Espinosa G; Graña-Gil G; Sánchez-Bursón J; González-Gay MA; Barnosi-Marín AC; Solans R; Fanlo P; Carballeira MR; Camps T; Castañeda S; Martín J; González-Escribano MF
    PLoS One; 2014; 9(7):e102100. PubMed ID: 25019531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epistatic Interaction of ERAP1 and HLA-B*51 in Iranian Patients with Behçet's Disease.
    Mahmoudi M; Ashraf-Ganjouei A; Javinani A; Shahram F; Meguro A; Mizuki N; Ahmadzadeh N; Jafarinejad-Farsangi S; Mostafaei S; Kavosi H; Faezi ST; Akhlaghi M; Davatchi F
    Sci Rep; 2018 Dec; 8(1):17612. PubMed ID: 30514861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of rs17482078 and rs27044 ERAP1 polymorphisms in a group of Italian Behçet's syndrome patients: a preliminary case-control study.
    Padula MC; Leccese P; Pellizzieri E; Padula AA; Gilio M; Carbone T; Lascaro N; Tramontano G; Martelli G; D'Angelo S
    Intern Emerg Med; 2019 Aug; 14(5):713-718. PubMed ID: 30820838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1.
    Kirino Y; Bertsias G; Ishigatsubo Y; Mizuki N; Tugal-Tutkun I; Seyahi E; Ozyazgan Y; Sacli FS; Erer B; Inoko H; Emrence Z; Cakar A; Abaci N; Ustek D; Satorius C; Ueda A; Takeno M; Kim Y; Wood GM; Ombrello MJ; Meguro A; Gül A; Remmers EF; Kastner DL
    Nat Genet; 2013 Feb; 45(2):202-7. PubMed ID: 23291587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The correlation of endoplasmic reticulum aminopeptidase 1 polymorphisms with Behçet's disease: a meta-analysis.
    Gao W; Jin X; Zhou P; Zhu H; Xie K; Jin B; Du L
    Clin Exp Rheumatol; 2023 Oct; 41(10):2027-2038. PubMed ID: 37083156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of ERAP1 coding variants and domain specific interaction with HLA-C∗06 in the early onset psoriasis patients of India.
    Das A; Chandra A; Chakraborty J; Chattopadhyay A; Senapati S; Chatterjee G; Chatterjee R
    Hum Immunol; 2017 Nov; 78(11-12):724-730. PubMed ID: 28867178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single endoplasmic reticulum aminopeptidase-1 protein allotype is a strong risk factor for Behçet's disease in HLA-B*51 carriers.
    Takeuchi M; Ombrello MJ; Kirino Y; Erer B; Tugal-Tutkun I; Seyahi E; Özyazgan Y; Watts NR; Gül A; Kastner DL; Remmers EF
    Ann Rheum Dis; 2016 Dec; 75(12):2208-2211. PubMed ID: 27217550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of an ERAP1 haplotype in ankylosing spondylitis: investigating non-MHC genes in HLA-B27-positive individuals.
    Bettencourt BF; Rocha FL; Alves H; Amorim R; Caetano-Lopes J; Vieira-Sousa E; Pimentel-Santos F; Lima M; Porto G; Branco JC; Fonseca JE; Bruges-Armas J
    Rheumatology (Oxford); 2013 Dec; 52(12):2168-76. PubMed ID: 24046467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redundancy and Complementarity between ERAP1 and ERAP2 Revealed by their Effects on the Behcet's Disease-associated HLA-B*51 Peptidome.
    Guasp P; Lorente E; Martín-Esteban A; Barnea E; Romania P; Fruci D; Kuiper JW; Admon A; López de Castro JA
    Mol Cell Proteomics; 2019 Aug; 18(8):1491-1510. PubMed ID: 31092671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behçet's disease risk-variant HLA-B51/ERAP1-Hap10 alters human CD8 T cell immunity.
    Cavers A; Kugler MC; Ozguler Y; Al-Obeidi AF; Hatemi G; Ueberheide BM; Ucar D; Manches O; Nowatzky J
    Ann Rheum Dis; 2022 Nov; 81(11):1603-1611. PubMed ID: 35922122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of an Unconventional Subpeptidome Bound to the Behçet's Disease-associated HLA-B*51:01 that is Regulated by Endoplasmic Reticulum Aminopeptidase 1 (ERAP1).
    Chen L; Shi H; Koftori D; Sekine T; Nicastri A; Ternette N; Bowness P
    Mol Cell Proteomics; 2020 May; 19(5):871-883. PubMed ID: 32161166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERAP1 polymorphisms and haplotypes are associated with ankylosing spondylitis susceptibility and functional severity in a Spanish population.
    Szczypiorska M; Sánchez A; Bartolomé N; Arteta D; Sanz J; Brito E; Fernández P; Collantes E; Martínez A; Tejedor D; Artieda M; Mulero J
    Rheumatology (Oxford); 2011 Nov; 50(11):1969-75. PubMed ID: 21865284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Behçet's disease-associated variant of the aminopeptidase ERAP1 shapes a low-affinity HLA-B*51 peptidome by differential subpeptidome processing.
    Guasp P; Barnea E; González-Escribano MF; Jiménez-Reinoso A; Regueiro JR; Admon A; López de Castro JA
    J Biol Chem; 2017 Jun; 292(23):9680-9689. PubMed ID: 28446606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A proposed HLA-B*27 screening method for ankylosing spondylitis detection based on tag-single nucleotide polymorphisms: a preliminary study.
    Martínez-Nava GA; Zamudio-Cuevas Y; Terrazas-Ontiveros NA; Martínez-Flores K; Espinosa-Morales R; Mijares-Díaz F; Juárez-Barreto SM; Lozada-Pérez C; Valdés-Flores M; Sánchez-Sánchez R; Hidalgo-Bravo A; Fernández-Torres J
    Mol Biol Rep; 2021 Dec; 48(12):7819-7829. PubMed ID: 34643924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From structure to function for the characterization of ERAP1 active site in Behçet syndrome. A novel polymorphism associated with known gene variations.
    Padula MC; Leccese P; Lascaro N; Carbone T; Limongi AR; Radice RP; Padula AA; D'Angelo S; Martelli G
    Mol Immunol; 2020 Jan; 117():155-159. PubMed ID: 31790864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of ERAP1 and ERAP2 single nucleotide polymorphisms and their haplotypes with psoriasis vulgaris is dependent on the presence or absence of the HLA-C*06:02 allele and age at disease onset.
    Wiśniewski A; Matusiak Ł; Szczerkowska-Dobosz A; Nowak I; Łuszczek W; Kuśnierczyk P
    Hum Immunol; 2018 Feb; 79(2):109-116. PubMed ID: 29183862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between ERAP1 polymorphisms and ankylosing spondylitis susceptibility in HLA-B27 positive population: a Meta-analysis and bioinformatics analysis.
    Bai Y; Zhao N; Sun H; Yin L; Chen J; Hu N
    Nucleosides Nucleotides Nucleic Acids; 2022; 41(4):407-418. PubMed ID: 35139766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERAP1 and HLA-C interaction in inflammatory bowel disease in the Spanish population.
    Castro-Santos P; Moro-García MA; Marcos-Fernández R; Alonso-Arias R; Díaz-Peña R
    Innate Immun; 2017 Jul; 23(5):476-481. PubMed ID: 28651467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERAP1 polymorphisms interactions and their association with Behçet's disease susceptibly: Application of Model-Based Multifactor Dimension Reduction Algorithm (MB-MDR).
    Riahi P; Kazemnejad A; Mostafaei S; Meguro A; Mizuki N; Ashraf-Ganjouei A; Javinani A; Faezi ST; Shahram F; Mahmoudi M
    PLoS One; 2020; 15(2):e0227997. PubMed ID: 32023277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERAP1-ERAP2 haplotypes are associated with ankylosing spondylitis in Polish patients.
    Wiśniewski A; Kasprzyk S; Majorczyk E; Nowak I; Wilczyńska K; Chlebicki A; Zoń-Giebel A; Kuśnierczyk P
    Hum Immunol; 2019 May; 80(5):339-343. PubMed ID: 30794838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.